Quantitative Analysis of Factors of Attrition in a Double-blind rTMS Study for Alzheimer Treatment

被引:0
|
作者
Bretecher, Carly A. [1 ]
Verot, Ashley [1 ]
Teschuk, James M. [1 ]
Uehara, Maria A. [1 ]
Fitzgerald, Paul B. [2 ]
Koski, Lisa [3 ]
Lithgow, Brian J. [1 ]
Moussavi, Zahra [1 ]
机构
[1] Univ Manitoba, Biomed Engn, 75 Chancellor Circle, Winnipeg, MB R3T5V6, Canada
[2] Australian Natl Univ, Sch Med & Psychol, Canberra, Australia
[3] McGill Univ, Dept Med, Montreal, PQ, Canada
来源
ALZHEIMER DISEASE & ASSOCIATED DISORDERS | 2024年 / 38卷 / 03期
基金
英国医学研究理事会;
关键词
Alzheimer disease; rTMS; participant attrition; dementia; STIMULATION; DEPRESSION; SCALE;
D O I
10.1097/WAD.0000000000000633
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Attrition is a particular concern in studies examining the efficacy of a treatment for Alzheimer disease. Analyzing reasons for withdrawal in Alzheimer studies is crucial to ruling out attrition bias, which can undermine a study's validity. In contrast, attrition in studies using repetitive transcranial magnetic stimulation (rTMS) has received much less attention. Our goal was to identify any commonalities between participants who withdrew for the same reasons. Three independent coders rated each response concerning the reasons for withdrawal, and frequency tables were generated to characterize the participants within each category. This study was conducted on the 28 withdrawn cases from a 7-month study investigating the short-term and long-term therapeutic effects of rTMS for Alzheimer disease among 156 participants across 3 sites of the study. Seven reasons for withdrawal were identified, with health and medical changes being the most commonly reported reason (7 participants). Personal issues involving family or caregivers were the next most common (5 participants), and the remaining 5 categories consisted of 3 participants each. Although the limited sample size prevented the use of inferential statistics, our findings highlight the need for more transparent reporting of attrition rates and withdrawal reasons by rTMS researchers.
引用
收藏
页码:288 / 291
页数:4
相关论文
共 50 条
  • [1] DOUBLE-BLIND STUDY OF TREATMENT OF HYPERTENSION
    GRENFELL, RF
    BRIGGS, AH
    HOLLAND, WC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 176 (02): : 124 - &
  • [2] A negative double-blind controlled trial of sequential bilateral rTMS in the treatment of bipolar depression
    Fitzgerald, Paul B.
    Hoy, Kate E.
    Elliot, David
    McQueen, Susan
    Wambeek, Lenore E.
    Daskalakis, Zafiris J.
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 198 : 158 - 162
  • [3] IS A DOUBLE-BLIND DRUG STUDY REALLY DOUBLE-BLIND
    QUAK, J
    BERNARDIS, B
    HALBREICH, U
    BIOLOGICAL PSYCHIATRY, 1994, 35 (09) : 741 - 741
  • [4] TRAZODONE IN TREATMENT OF PSYCHONEUROSES - DOUBLE-BLIND STUDY
    ANTONELLI, F
    DEGREGOR.M
    DIONISIO, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1973, 15 (10): : 799 - 804
  • [5] TREATMENT OF PRIMARY DYSMENORRHEA - A DOUBLE-BLIND STUDY
    AYDAR, CK
    COLEMAN, BD
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 192 (11): : 1003 - &
  • [6] Misoprostol in the treatment of tinnitus:: A double-blind study
    Yilmaz, I
    Akkuzu, B
    Çakmak, O
    Özlüoglu, LN
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2004, 130 (05) : 604 - 610
  • [7] A DOUBLE-BLIND STUDY OF TRASYLOL IN TREATMENT OF PANCREATITIS
    BACHRACH, WH
    SCHILD, PD
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 146 (A2) : 580 - +
  • [8] RNA TREATMENT OF DEMENTIA - DOUBLE-BLIND STUDY
    MUNCHPETERSEN, S
    PAKKENBERG, H
    KORNERUP, H
    ORTMANN, J
    IPSEN, E
    JACOBSEN, P
    SIMMELSGARD, H
    ACTA NEUROLOGICA SCANDINAVICA, 1974, 50 (05): : 553 - 572
  • [9] DOUBLE-BLIND STUDY OF AZARIBINE IN TREATMENT OF PSORIASIS
    VOGLER, WR
    OLANSKY, S
    ANNALS OF INTERNAL MEDICINE, 1970, 73 (06) : 951 - +
  • [10] TREATMENT OF ANGINA PECTORIS - A DOUBLE-BLIND STUDY
    SAPIENZA, PL
    CLINICAL MEDICINE, 1968, 75 (12) : 30 - &